A Phase I Trial of Ipilimumab (IPI) in Patients (PTS) with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent (HMAS) Failure

Zeidan, A ; Knaus, H ; Robinson, T ; Zeidner, J ; Blackford, A ; Duffield, A ; Rizzieri, D ; Frattini, M ; Levy, M.Y ; Schroeder, M ; Ferguson, A ; Sheldon, K ; Dezern, A ; Gojo, I ; Gore, S ; Streicher, H ; Luznik, L ; Smith, B.D

Texto completo disponível

Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study

Goldberg, Aaron D. ; Atallah, Ehab ; Rizzieri, David ; Walter, Roland B. ; Chung, Ki-Young ; Spira, Alexander ; Stock, Wendy ; Tallman, Martin S. ; Cruz, Hans G. ; Boni, Joseph ; Havenith, Karin E.G. ; Chao, Grace ; Feingold, Jay M. ; Wuerthner, Jens ; Solh, Melhem

Elsevier Ltd

Texto completo disponível

64 - A Phase I Trial of Ipilimumab (IPI) in Patients (PTS) with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent (HMAS) Failure

Zeidan, A. ; Knaus, H. ; Robinson, T. ; Zeidner, J. ; Blackford, A. ; Duffield, A. ; Rizzieri, D. ; Frattini, M. ; Levy, M.Y. ; Schroeder, M. ; Ferguson, A. ; Sheldon, K. ; Dezern, A. ; Gojo, I. ; Gore, S. ; Streicher, H. ; Luznik, L. ; Smith, B.D.

Elsevier Ltd

Texto completo disponível

Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia

Morris, Tod A ; DeCastro, Carlos M ; Diehl, Louis F ; Gockerman, Jon P ; Lagoo, Anand S ; Li, Zhiguo ; Moore, Joseph O ; Rizzieri, David A ; Rao, Arati V

England: Elsevier Ltd

Texto completo disponível

Elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia

Giles, Francis ; Rizzieri, David ; Ravandi, Farhad ; Swords, Ronan ; Jacobsen, Tove Flem ; O’Brien, Susan

England: Elsevier Ltd

Texto completo disponível

P129 A pilot study of decitabine in combination with arsenic trioxide for patients with myelodysplastic syndromes

de Castro, C ; Adams, D ; Rizzieri, D ; Moore, J ; Gockerman, J ; Diehl, L ; Horwitz, M ; Edmonds, E ; Warzecho, J

Elsevier Ltd

Texto completo disponível

P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes

de Castro, C ; Adams, D ; Rizzieri, D ; Moore, J ; Gockerman, J ; Diehl, L ; Horwitz, M ; Edmonds, E ; Warzecho, J

Elsevier Ltd

Texto completo disponível

Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia

Laughlin, Mary J. ; Rizzieri, David A. ; Smith, Clayton A. ; Moore, Joseph O. ; Lilly, Scott ; McGaughey, Dean ; Martin, P. ; Carrier, Carmellita ; Stevens, Cladd E. ; Rubinstein, Pablo ; Buckley, Rebecca ; Kurtzberg, Joanne

Oxford: Elsevier Ltd

Texto completo disponível

Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat disease

Guerrero-Garcia, Thomas A. ; Mogollon, Renzo J. ; Castillo, Jorge J.

England: Elsevier Ltd

Texto completo disponível

Outcomes of fludarabine, high dose cytarabine and granulocyte-colony stimulating factor (FLAG) as re-induction for residual acute myeloid leukemia on day 14 bone marrow

Jamy, Omer ; Bae, Sejong ; Costa, Luciano J. ; Erba, Harry P. ; Papadantonakis, Nikolaos

England: Elsevier Ltd

Texto completo disponível